Endothelins: a Possible Mechanism of Cytostatics-induced Cardiomyopathy

References

• Ferlay, J., Bray, F., Pisciani, P. and Parkin, D.M. (2001) GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0 IARC Cancer Base No. 5. Lyon, IARC Press.
   Google Scholar
• Pai, V.B. and Nahata, M.C. (2000) "Cardiotoxicity of Chemother-apeutic Agents", Drug Safety, 22, 263–302.
   PubMed Web of Science ®Google Scholar
• Lefrak, E.A., Pitha, J., Rosenheim, S. and Gottlieb, J.A. (1973) "A clinicopathologic analysis of Adriamycin cardiotoxicity", Cancer, 32, 302–314.
   Google Scholar
• Steinherz, L.J., Steinherz, P.G., Tann, C.T., Heller, G. and Murphy, M.L. (1991) "Cardiac toxicity 4 to 20 years after completing anthracycline therapy", Journal of the American Medical Associa-tion, 266, 1672–1677.
   Google Scholar
• Bristoww, M.R., Billingham, M.E., Masson, J.W. and Daniels, J.R. (1978) "Clinical spectrum of anthracycline antibiotic cardiotoxi-city", Cancer Treatment Reports, 62, 873–879.
   Google Scholar
• Singal, P.K., Iliskovic, N. (1998) "Current Concepts: Doxorubicin-Induced Cardiomyopathy", The New England Journal of Medicine, 339(13), 900–905.
   PubMed Web of Science ®Google Scholar
• Raitakari, O.T. and Celermajer, D.S. (2000) "Testing for endothe-lial dysfunction", Annals of Medicine, 32, 293–304.
   Web of Science ®Google Scholar
• Mebazaa, A., De Keulenaer, G.W., Paqueron, X. et al. (2001) "Activation of cardiac endothelium as a compensatory component in endotoxin-induced cardiomyopathy", Circulation, 104, 3137–3144.
   Google Scholar
• Shah, A.M. (1996) "Paracrine modulation of heart cell function by endothelial cells", Cardiovascular Research, 31, 847–867.
   Google Scholar
• Kell, R. Haunstetter, A., Dengler, T.J., Zugck, C., Kfibler, W. and Haass, M. (2002) "Do cytokines enable risk stratification to be improved in NYHA functional class III patients?", The European Heart Journal, 23, 70–78.
   Google Scholar
• Margulies, KB., Hildebrand, F.L Jr, Lerman, A., Perrella, M.A. and Burnett, J.C. Jr. (1990) "Increased endothelin in experimental heart failure. Circulation, 82, 2226–2230.
   PubMed Web of Science ®Google Scholar
• Wei, C.-M., Lerman, A., Rodeheffer, R.J., McGregor, C.G.A., Brandt, R.R., Wright, S. et al. (1994) "Endothelin in human congestive heart failure", Circulation, 89, 1580–1586.
   Google Scholar
• McKelvey, EM., Gottlieb, JA., Wilson, H.E. et al. (1976) "Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma", Cancer, 38, 1484–1493.
   Google Scholar
• Bonadonna, G. and Santoro, A. (1982) "ABVD chemotherapy in the treatment of Hodgkin's disease (Review)", Cancer Treatment Reviews, 9, 21–35.
   PubMed Web of Science ®Google Scholar
• Folland, ED., Parisi, A.F., Moynihan, P.F., Jones, DR., Feldman, C.L. and Tow, D.E. (1979) "Assessment of left ventricular ejection fraction and volumes by real-time two-dimensional echocardiogra-phy", Circulation, 60, 760–766.
   Google Scholar
• Dujardin, KS., Tei, C., Yeo, T.C., Hodge, DO., Rossi, A. and Stewart, J.B. (1998) "Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic dilated cardiomyopathy", American Journal of Cardiology, 82, 1071–1076.
   Google Scholar
• Cheitlin M.D., Alpert, JS., Armstrong, W.F., Aurigemma, G.P., Beller, G.A., Bierman, F.Z. et al. (1997) "ACC/AHA Guidelines for the clinical application of echocardiography", Circulation, 95, 1686–1744.
   Google Scholar
• Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, J., Kobayashi, M., Mitsui, Y. et al. (1988) "A novel potent vasoconstrictor peptide produced by vascular endothelial cells", Nature, 332, 411–415.
   Google Scholar
• Nakamura, S., Naruse, M., Naruse, K., Demura, H. and Uemura, H. (1990) "Immuncytochemical localization of endothelin in cultured bovine endothelial cells", Histochemistry, 94, 475–477.
   Google Scholar
• Levin, E.R. (1995) "Endothelins", The New England Journal of Medicine, 333, 356–361.
   PubMed Web of Science ®Google Scholar
• De Artinano, A.A. and Gonzalez, V.I. (1999) "Endothelial dysfunction and hypertensive vasoconstriction", Pharmacological Research, 40, 113–124.
   Google Scholar
• Heitzer, T., Schlinzing, T., Krohn, K., Meinertz, T. and Mfinzel, T. (2001) "Endothelial dysfunction, oxidative stress and risk of cardiovascular events in patients with coronary artery disease", Circulation, 104, 2673–2678.
   Google Scholar
• Masaki, T. (2000) "The endothelin family: An overview", Journal of Cardiovascular Pharmacology, 35, 3–5.
   PubMed Web of Science ®Google Scholar
• Suzuki, T. and Miyauchi, T. (2001) "A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes", American Journal of Physiology, Regulatory Integrative and Comperative Physiology, 280, 1399–1406.
   Google Scholar
• Chu, L. and Endoh, M. (2000) "Biphasic inotropic response to endothelin-1 in the presence of various concentrations of norepi-nephrine in dog ventricular myocardium", Journal of Cardiovascular Pharmacology, 36, 9–14.
   Web of Science ®Google Scholar
• Yamashita, J., Ogawa, M. and Shirakusa, T. (1995) "Plasma endothelin-1 as a marker for doxorubicin cardiotoxicity", Interna-tional Journal of Cancer, 62, 542–547.
   Google Scholar
• Sakai, S., Miyauchi, T., Sakurai, T., Kasuya, Y., Ihara, M., Yamaguchi, I. et al. (1996) "Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart", Circulation, 93, 1214 — 1222.
   Google Scholar
• Mostafa, M.G., Mima, T., Taniguchi, T. and Mori, K. (2000) "Doxorubicin an RNA synthesis inhibitor, prevents vaso-constriction and inhibits aberrant expression of endothelin-1 in cerebral vasospasm model of the rat", Neuroscience Letters, 283, 197— 200.
   Google Scholar
• Myers, C. (1998) "The role of iron in doxorubicin-induced cardiomyopathy", Seminars in Oncology, 25, 10 — 14.
   Google Scholar
• Ganz, W.I., Sridhar, KS., Ganz, S.S., Gonzalez, R., Chakko, S. and Serafini, A. (1996) "Review of tests for monitoring doxorubicin-induced cardiomyopathy". Oncology, 53(6), 461 —470.
   Google Scholar
• Kelso, E.J., Geraghty, R.F., McDermott, B.J., Trimble, E.R., Nicholls, D.P. and Silke, B. (1996) "Mechanical effects of ET-1 in cardiomyocytes isolated from normal and heart-failed rabbits", Molecular and Cellular Biochemistry, 157, 149 — 155.
   Google Scholar